NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Press Release

NuVasive to Showcase Integrated Global Alignment Platform at North American Spine Society 30th Annual Meeting

SAN DIEGO, CA -- (Marketwired) -- 10/13/15 -- NuVasive, Inc.(NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive and procedurally integrated solutions, today announced that it will attend the North American Spine Society (NASS) 30th Annual Meeting held October 14-17, 2015 at McCormick Place West in Chicago, IL. The Company's attendance highlights NuVasive's ongoing commitment to surgeon support through numerous education workshops and exhibitions of several of the Company's products and procedures, including its recently launched Integrated Global Alignment (iGA™) platform, all of which continue to transform and advance spine surgery tools and techniques.

Gregory T. Lucier, NuVasive Chairman and Chief Executive Officer, said, "NuVasive's consistent drive to bring game-changing technologies to address unmet needs and improve patient outcomes positions us as the clear disruptive innovator in the spine market. This year at NASS, we are bringing our leadership position to a whole new level by showcasing NuVasive's revolutionary iGA platform. iGA represents a fundamental shift in the traditional approach to spine surgery, bringing together the best of our technology, tools and software into one procedurally-integrated platform to address the most correlative element of successful, long-term surgical outcomes -- proper alignment. With overwhelming clinical evidence clearly demonstrating the imperative role that preoperative and intraoperative measuring plays in achieving sagittal alignment goals, NASS provides us with an outstanding forum to rapidly broaden awareness of the iGA platform among both deformity and degenerative surgeons as we look to reshape how spine surgery is performed at every level."

NuVasive's NASS Exhibit Booth (#1647) Details

Surgeon support and collaboration will be the cornerstone to NuVasive's presence at NASS as the Company exhibits products and procedural innovations that align closely with surgeon needs. Surgeon education will also be a central focus with the Company providing hands-on, in-booth product demonstrations, numerous surgical workshops and other learning opportunities. This year, NuVasive will provide a particular emphasis on showcasing NuVasive's iGA platform through an enhanced exhibit booth experience and new digital assets designed to better engage NASS attendees in more clinically relevant and compelling ways that build better understanding around the value of the Company's procedurally-integrated solutions.

In addition, the Company will present its products and procedural innovations that have enabled NuVasive to become the third largest player in the $9 billion global spine market. NuVasive's latest product innovations like Archon® Reconstruction, VuePoint® II, Cervical ACR®, Osteocel® Pro biologic, and the XLIF Decade™ Plate, X-Core®2 and StruXure™ for XLIF®, along with new procedures like ALIF and XLIF ACR with integrated Bendini® Spinal Rod Bending System to correct sagittal alignment, will be showcased at the NuVasive exhibit booth (#1647). NuVasive will also feature its industry-leading MAS® PLIF, MAS and anterior TLIF, and XLIF procedural solutions at its NASS exhibit.

NuVasive's in-booth presentations at the NASS 2015 Annual Meeting include:

Wednesday, October 14, 2015

  • 10:00 a.m. to 10:30 a.m. CT - Importance of pre-op planning and intra-op assessment for degenerative disorders presented by Dr. Regis Haid
  • 12:00 p.m. to 1:00 p.m. CT - Methods of pre-op planning and intra-op assessment presented by Dr. Stephen Ryu
  • 3:05 p.m. to 3:35 p.m. CT - Anterior Column Realignment (ACR®) Anterior Techniques to Restore Spinal Alignment presented by Dr. Vedat Deviren and Dr. Juan Uribe

Thursday, October 15, 2015

  • 9:10 a.m. to 9:40 a.m. CT - Importance of pre-op planning and intra-op assessment for degenerative disorders presented by Dr. Regis Haid
  • 12:00 p.m. to 1:00 p.m. CT - Methods of pre-op planning and intra-op assessment presented by Dr. Stephen Ryu
  • 3:10 p.m. to 3:40 p.m. CT - Anterior Column Realignment (ACR) Anterior Techniques to Restore Spinal Alignment by Dr. Vedat Deviren and Dr. William Smith

For more information, view the online NASS program or visit the NASS 2015 website.

About Integrated Global Alignment

Integrated Global Alignment is a proprietary, procedurally-integrated digital platform enabling precise spinal column alignment. The multi-product suite of spine surgical devices forms a complete procedural platform and operating philosophy that centers on the critical importance of proper alignment. The launch of the iGA platform includes a suite of alignment focused offerings, such as the introduction of next generation fixation, anterior and posterior implants, updated neuromonitoring and computer-assisted rod bending and surgical planning technology. It is this combination of procedurally-based technologies that are unique to NuVasive and designed to enhance clinical outcomes by increasing the predictability of achieving global alignment in spinal procedures.

About NuVasive

NuVasive is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the third largest player in the $9.0 billion global spine market. NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company's principal procedural solution is its Maximum Access Surgery, or MAS, platform for lateral spine fusion. MAS was designed to provide safer, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.

NuVasive cautions you that statements included in this news release or made during the Eurospine 2015 that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Media Contacts:
Stacy Roughan
NuVasive, Inc.
Email contact

Joanna Zimmerman
The Ruth Group
Email contact

Source: NuVasive, Inc.